Cargando…

Quantification of Phenotypic Variability of Lung Disease in Children with Cystic Fibrosis

Cystic fibrosis (CF) lung disease has the greatest impact on the morbidity and mortality of patients suffering from this autosomal-recessive multiorgan disorder. Although CF is a monogenic disorder, considerable phenotypic variability of lung disease is observed in patients with CF, even in those ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stahl, Mirjam, Steinke, Eva, Mall, Marcus A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229033/ https://www.ncbi.nlm.nih.gov/pubmed/34070354 http://dx.doi.org/10.3390/genes12060803

Ejemplares similares

Reply to Dournes et al.: Contrast-enhanced Magnetic Resonance Imaging Does Not Detect a Progression in Lung Morphological Score in Preschool Children with Cystic Fibrosis
por: Stahl, Mirjam, et al.
Publicado: (2021)

TRACK-CF prospective cohort study: Understanding early cystic fibrosis lung disease
por: Steinke, Eva, et al.
Publicado: (2023)

Neutrophil elastase and matrix metalloproteinase 12 in cystic fibrosis lung disease
por: Wagner, Claudius J., et al.
Publicado: (2016)

Comparison of Oropharyngeal Microbiota from Children with Asthma and Cystic Fibrosis
por: Boutin, Sébastien, et al.
Publicado: (2017)

Magnetic resonance imaging detects onset and association with lung disease severity of bronchial artery dilatation in cystic fibrosis
por: Leutz-Schmidt, Patricia, et al.
Publicado: (2023)

A Volatile and Dynamic Longitudinal Microbiome Is Associated With Less Reduction in Lung Function in Adolescents With Cystic Fibrosis
por: Metzger, Marisa I., et al.
Publicado: (2021)

Impact of lockdown during the COVID-19 pandemic on health status in patients with cystic fibrosis: a mono-centre observational study
por: Thee, Stephanie, et al.
Publicado: (2022)

Multicentre feasibility of multiple-breath washout in preschool children with cystic fibrosis and other lung diseases
por: Stahl, Mirjam, et al.
Publicado: (2020)

Changes in Microbiome Dominance Are Associated With Declining Lung Function and Fluctuating Inflammation in People With Cystic Fibrosis
por: Frey, Dario L., et al.
Publicado: (2022)

Effects of lumacaftor—ivacaftor therapy on cystic fibrosis transmembrane conductance regulator function in F508del homozygous patients with cystic fibrosis aged 2–11 years
por: Berges, Julian, et al.
Publicado: (2023)

Effects of elexacaftor/tezacaftor/ivacaftor therapy on mental health of patients with cystic fibrosis
por: Piehler, Linus, et al.
Publicado: (2023)

Potential of Intestinal Current Measurement for Personalized Treatment of Patients with Cystic Fibrosis
por: Graeber, Simon Y., et al.
Publicado: (2021)

Comparison of Microbiomes from Different Niches of Upper and Lower Airways in Children and Adolescents with Cystic Fibrosis
por: Boutin, Sébastien, et al.
Publicado: (2015)

BPIFB1 (LPLUNC1) is upregulated in cystic fibrosis lung disease
por: Bingle, Lynne, et al.
Publicado: (2012)

Airway disease phenotypes in animal models of cystic fibrosis
por: McCarron, Alexandra, et al.
Publicado: (2018)

New Developments in Cystic Fibrosis Airway Inflammation
por: Palaniyar, Nades, et al.
Publicado: (2015)

Cystic Fibrosis: Clinical Phenotypes in Children and Adolescents
por: dos Santos, Ana Luiza Melo, et al.
Publicado: (2018)

Role of the SLC26A9 Chloride Channel as Disease Modifier and Potential Therapeutic Target in Cystic Fibrosis
por: Balázs, Anita, et al.
Publicado: (2018)

ENaC inhibition in cystic fibrosis: potential role in the new era of CFTR modulator therapies
por: Mall, Marcus A.
Publicado: (2020)

Lung clearance index to characterize clinical phenotypes of children and adolescents with cystic fibrosis
por: Gambazza, Simone, et al.
Publicado: (2022)

Long-term effects of lumacaftor/ivacaftor on paranasal sinus abnormalities in children with cystic fibrosis detected with magnetic resonance imaging
por: Wucherpfennig, Lena, et al.
Publicado: (2023)

MDCT-based longitudinal automated airway and air trapping analysis in school-age children with mild cystic fibrosis lung disease
por: Weinheimer, Oliver, et al.
Publicado: (2023)

Genetic Deletion of Mmp9 Does Not Reduce Airway Inflammation and Structural Lung Damage in Mice with Cystic Fibrosis-like Lung Disease
por: Wagner, Claudius, et al.
Publicado: (2022)

Optimal treatment of the underlying aetiology is the most effective antimicrobial stewardship for chronic respiratory disease: a lesson learned from cystic fibrosis
por: Rademacher, Jessica, et al.
Publicado: (2023)

Lung Microbiome in Cystic Fibrosis
por: Scialo, Filippo, et al.
Publicado: (2021)

Reproducibility of Heart Rate Variability Indices in Children with Cystic Fibrosis
por: McNarry, Melitta A., et al.
Publicado: (2016)

The Chitinase-Like Protein YKL-40 Modulates Cystic Fibrosis Lung Disease
por: Hector, Andreas, et al.
Publicado: (2011)

Phenotypic Presentations of Cystic Fibrosis in Children of African Descent
por: Mayer Lacrosniere, Sophie, et al.
Publicado: (2021)

Pathophysiology of Lung Disease and Wound Repair in Cystic Fibrosis
por: Conese, Massimo, et al.
Publicado: (2021)

Cystic fibrosis-related diabetes and lung disease: an update
por: Prentice, Bernadette J., et al.
Publicado: (2021)

A multi-centre, randomized, controlled trial on coaching and telemonitoring in patients with cystic fibrosis: conneCT CF
por: Thee, Stephanie, et al.
Publicado: (2021)

Potential of anti-inflammatory treatment for cystic fibrosis lung disease
por: Taylor-Cousar, Jennifer L, et al.
Publicado: (2010)

Cystic fibrosis transmembrane conductance regulator in COPD: a role in respiratory epithelium and beyond
por: Mall, Marcus A., et al.
Publicado: (2023)

Personalized CFTR Modulator Therapy for G85E and N1303K Homozygous Patients with Cystic Fibrosis
por: Graeber, Simon Y., et al.
Publicado: (2023)

CFTR Modulator Therapy with Lumacaftor/Ivacaftor Alters Plasma Concentrations of Lipid-Soluble Vitamins A and E in Patients with Cystic Fibrosis
por: Sommerburg, Olaf, et al.
Publicado: (2021)

Phenotypic and Genomic Variability of Serial Peri-Lung Transplantation Pseudomonas aeruginosa Isolates From Cystic Fibrosis Patients
por: Datar, Rucha, et al.
Publicado: (2021)

Biomarkers in Cystic Fibrosis Lung Disease – A Review
por: Ciuca, Ioana Mihaiela, et al.
Publicado: (2020)

Nutritional Care in Children with Cystic Fibrosis
por: Mariotti Zani, Elena, et al.
Publicado: (2023)

Rhinovirus Infection Is Associated With Airway Epithelial Cell Necrosis and Inflammation via Interleukin-1 in Young Children With Cystic Fibrosis
por: Montgomery, Samuel T., et al.
Publicado: (2020)

Best practices in the treatment of early cystic fibrosis lung disease
por: Proesmans, Marijke
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ij1d2rhscjrfb53up6lp1bug31